Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation.

Mansier O, Prouzet-Mauléon V, Jégou G, Barroso K, Raymundo DP, Chauveau A, Dumas PY, Lagarde V, Turcq B, Pasquet JM, Viallard JF, James C, Praloran V, Voutetakis K, Chatziioannou A, Mahon FX, Chevet E, Lippert E.

Cancers (Basel). 2019 Dec 2;11(12). pii: E1921. doi: 10.3390/cancers11121921.

2.

[Starry erythema under bortezomib].

Ducours M, Lazaro E, Machelart I, Greib C, Viallard JF, Rivière E.

Presse Med. 2019 Oct;48(10):1187-1189. doi: 10.1016/j.lpm.2019.09.007. Epub 2019 Oct 25. French. No abstract available.

PMID:
31669006
3.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B.

Am J Hematol. 2019 Dec;94(12):1314-1324. doi: 10.1002/ajh.25632. Epub 2019 Oct 8.

PMID:
31489694
4.

Cutaneous necrotizing small-vessel vasculitis induced by acute hepatitis E.

Viallard JF, Vergier B, Lazaro E, Greib C, Pellegrin JL.

Clin Case Rep. 2019 Jun 29;7(8):1539-1541. doi: 10.1002/ccr3.2167. eCollection 2019 Aug.

5.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Oct;39(7):702-712. doi: 10.1007/s10875-019-00658-9. Epub 2019 Aug 10.

PMID:
31401750
6.

Complete remission of immune thrombocytopenia in a 30-year old woman after excision of a right atrial myxoma.

Durand P, Furudoi A, Parrens M, Lazaro E, Viallard JF, Rivière E.

Br J Haematol. 2019 Oct;187(1):e18-e19. doi: 10.1111/bjh.16135. Epub 2019 Aug 6. No abstract available.

PMID:
31388989
7.

Visceral leishmaniasis with hemophagocytic lymphohistiocytosis in an immunocompetent adult.

Machelart I, Lapoirie J, Viallard JF, Mirabel M, Lazaro E, Greib C, Rivière E.

Med Mal Infect. 2019 Oct;49(7):548-550. doi: 10.1016/j.medmal.2019.07.006. Epub 2019 Jul 17. No abstract available.

PMID:
31326300
8.

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Dupuy H, Lazaro E, Machelart I, Viallard JF, Coppo P, Rivière E.

TH Open. 2018 Dec 5;2(4):e407-e410. doi: 10.1055/s-0038-1676357. eCollection 2018 Oct. No abstract available.

9.

Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT.

Rivière E, Schwartz P, Machelart I, Greib C, Pellegrin JL, Viallard JF, Lazaro E.

QJM. 2019 Sep 1;112(9):695-697. doi: 10.1093/qjmed/hcz148. No abstract available.

PMID:
31225618
10.

Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia.

Vial G, Rivière E, Raymond AA, James C, Di-Tommaso S, Dugot-Senant N, Dupuy JW, Yacoub M, Parrens M, Saltel F, Viallard JF.

Front Immunol. 2019 Mar 22;10:523. doi: 10.3389/fimmu.2019.00523. eCollection 2019.

11.

Extrafacial necrobiotic xanthogranuloma and monoclonal gammopathy: two cases.

Legrand A, Jullie ML, Ly S, Beylot-Barry M, Viallard JF, Calonje J, Bureau-Lenoir C, Doutre MS.

Int J Dermatol. 2019 Jun;58(6):e112-e114. doi: 10.1111/ijd.14416. Epub 2019 Mar 18. No abstract available.

PMID:
30883695
12.

First description of an IgM monoclonal antibody causing αII b β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia.

Pillois X, Guy A, Choquet É, James C, Tuffigo M, Viallard JF, Garcia C, Bordet JC, Jandrot-Perrus M, Payrastre B, Fiore M.

J Thromb Haemost. 2019 May;17(5):795-802. doi: 10.1111/jth.14424. Epub 2019 Apr 19.

PMID:
30868743
13.

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Jacquemin C, Augusto JF, Scherlinger M, Gensous N, Forcade E, Douchet I, Levionnois E, Richez C, Lazaro E, Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL, Viallard JF, Schaeverbeke T, Pascual V, Contin-Bordes C, Blanco P.

JCI Insight. 2018 Dec 20;3(24). pii: 122167. doi: 10.1172/jci.insight.122167.

14.

The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments.

Benbrahim O, Viallard JF, Choquet S, Royer B, Bauduer F, Decaux O, Crave JC, Fardini Y, Clerson P, Lévy V.

Hematology. 2019 Dec;24(1):173-182. doi: 10.1080/10245332.2018.1538001. Epub 2018 Nov 20.

PMID:
30458690
15.

Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications.

Turpin D, Furudoi A, Parrens M, Blanco P, Viallard JF, Duluc D.

Clin Immunol. 2018 Dec;197:130-138. doi: 10.1016/j.clim.2018.09.006. Epub 2018 Sep 13.

PMID:
30219667
16.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 2.

PMID:
30079582
17.

Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms.

Lapoirie J, Contis A, Guy A, Lifermann F, Viallard JF, Sentilhes L, James C, Duffau P.

J Matern Fetal Neonatal Med. 2020 Jan;33(1):49-56. doi: 10.1080/14767058.2018.1484097. Epub 2018 Jun 26.

PMID:
29945475
18.

Two cases of tacrolimus-induced neutropenia: A probably under-diagnosed cause of neutropenia after solid-organ transplantation.

Clément J, Taton B, Merville P, Viallard JF, Lazaro E, Couzi L, Rivière E.

Clin Transplant. 2018 Jul;32(7):e13295. doi: 10.1111/ctr.13295. Epub 2018 Jun 15. No abstract available.

PMID:
29907985
19.

Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients.

Bienvenu B, Cozon G, Mataix Y, Lachaud D, Alix A, Hoarau C, Antier D, Hachulla E, Brice S, Viallard JF, Tamisier S, Fauchais AL, Renon-Carron F, Clerson P, Fardini Y, Crave JC, Miossec P.

J Clin Immunol. 2018 May;38(4):503-512. doi: 10.1007/s10875-018-0507-x. Epub 2018 May 31.

20.

Gamma delta T cell expansion in Whipple's disease with muscular granulomatous vasculitis.

Brönnimann D, Vandenhende MA, Viallard JF.

Infection. 2018 Aug;46(4):573-576. doi: 10.1007/s15010-018-1143-3. Epub 2018 May 3.

PMID:
29725938
21.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Erratum in: Ann Rheum Dis. 2019 Sep;78(9):e101.

PMID:
29695500
22.

A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency.

Benbrahim O, Viallard JF, Choquet S, Royer B, Bauduer F, Decaux O, Crave JC, Fardini Y, Clerson P, Lévy V.

Eur J Haematol. 2018 Jul;101(1):48-56. doi: 10.1111/ejh.13078. Epub 2018 May 17.

PMID:
29644723
23.

[Usefulness of thiopurine methyltransferase polymorphism study and metabolites measurement for patients treated by azathioprine].

Guillotin V, Galli G, Viallard JF.

Rev Med Interne. 2018 Jun;39(6):421-426. doi: 10.1016/j.revmed.2017.12.007. Epub 2018 Jan 19. Review. French.

PMID:
29370945
24.

Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.

Mansier O, Luque Paz D, Ianotto JC, Le Bris Y, Chauveau A, Boyer F, Conejero C, Fitoussi O, Riou J, Adiko D, Touati M, Chauzeix J, Viallard JF, Béné MC, Giraudier S, Ugo V, Lippert E.

Am J Hematol. 2018 Aug;93(4):E84-E86. doi: 10.1002/ajh.25014. Epub 2018 Jan 12. No abstract available.

25.

Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.

Furudoï A, Rivière É, Lazaro E, Furudoï E, Viallard JF, Parrens M.

Am J Surg Pathol. 2018 Mar;42(3):401-412. doi: 10.1097/PAS.0000000000000994.

PMID:
29200102
26.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Jun;103(6):1074-1082. doi: 10.1002/cpt.885. Epub 2017 Nov 9. Corrected and republished in: Clin Pharmacol Ther. 2019 Aug;106(2):374-382.

27.

Erratum: Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia.

Slama B, Fain O, Maisonneuve H, Jourdan E, Viallard JF, Ouaja R, Alfa-Cissé O, Godeau B; Study Investigators.

Am J Blood Res. 2017 Jun 15;7(3):29. eCollection 2017.

28.

A multicentre, prospective, non-randomized, sequential, open-label trial to demonstrate the bioequivalence between intravenous immunoglobulin new generation (IGNG) and standard IV immunoglobulin (IVIG) in adult patients with primary immunodeficiency (PID).

Viallard JF, Brion JP, Malphettes M, Durieu I, Gardembas M, Schleinitz N, Hoarau C, Lazaro E, Puget S.

Rev Med Interne. 2017 Sep;38(9):578-584. doi: 10.1016/j.revmed.2017.05.009. Epub 2017 Jul 3.

PMID:
28683953
29.

Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.

Pineton de Chambrun M, Gousseff M, Mauhin W, Lega JC, Lambert M, Rivière S, Dossier A, Ruivard M, Lhote F, Blaison G, Alric L, Agard C, Saadoun D, Graveleau J, Soubrier M, Lucchini-Lecomte MJ, Christides C, Bosseray A, Levesque H, Viallard JF, Tieulie N, Lovey PY, Le Moal S, Bibes B, Malizia G, Abgueguen P, Lifermann F, Ninet J, Hatron PY, Amoura Z; EurêClark Study Group.

Am J Med. 2017 Oct;130(10):1219.e19-1219.e27. doi: 10.1016/j.amjmed.2017.05.023. Epub 2017 Jun 9.

PMID:
28602874
30.

Renal Intravascular Large B-cell Lymphoma: A Case Report and Review of the Literature.

Desclaux A, Lazaro E, Pinaquy JB, Yacoub M, Viallard JF.

Intern Med. 2017;56(7):827-833. doi: 10.2169/internalmedicine.56.6406. Epub 2017 Apr 1.

31.

Graft infection after a Bentall procedure: A case series and systematic review of the literature.

Machelart I, Greib C, Wirth G, Camou F, Issa N, Viallard JF, Pellegrin JL, Lazaro E.

Diagn Microbiol Infect Dis. 2017 Jun;88(2):158-162. doi: 10.1016/j.diagmicrobio.2017.03.002. Epub 2017 Mar 7. Review.

PMID:
28330738
32.

Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia.

Slama B, Fain O, Maisonneuve H, Jourdan E, Viallard JF, Ouaja R, Alfa-Cissé O, Godeau B; Study Investigators.

Am J Blood Res. 2017 Jan 15;7(1):1-9. eCollection 2017. Erratum in: Am J Blood Res. 2017 Jun 15;7(3):29.

33.

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance.

Grimaldi-Bensouda L, Rossignol M, Koné-Paut I, Krivitzky A, Lebrun-Frenay C, Clet J, Brassat D, Papeix C, Nicolino M, Benhamou PY, Fain O, Costedoat-Chalumeau N, Courcoux MF, Viallard JF, Godeau B, Papo T, Vermersch P, Bourgault-Villada I, Breart G, Abenhaim L; PGRx-AD Study Group.

J Autoimmun. 2017 May;79:84-90. doi: 10.1016/j.jaut.2017.01.005. Epub 2017 Feb 9.

34.

Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.

Contis A, Gensous N, Viallard JF, Goizet C, Léauté-Labrèze C, Duffau P.

Clin Otolaryngol. 2017 Aug;42(4):911-917. doi: 10.1111/coa.12821. Epub 2017 Jan 20. No abstract available.

PMID:
28032956
35.

[Management of adverse effects related to human immunoglobulin therapy: Recommendations for clinical practice].

Marie I, Chérin P, Michallet M, Pelus E, Dantal J, Crave JC, Delain JC, Viallard JF.

Rev Med Interne. 2017 May;38(5):312-319. doi: 10.1016/j.revmed.2016.10.390. Epub 2016 Nov 21. Review. French.

PMID:
27884454
36.

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial.

Viallard JF, Agape P, Barlogis V, Cozon G, Faure C, Fouyssac F, Gaud C, Gourin MP, Hamidou M, Hoarau C, Husseini F, Ojeda-Uribe M, Pavic M, Pellier I, Perlat A, Schleinitz N, Slama B.

BMC Immunol. 2016 Sep 29;17(1):34.

37.

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.

Steurer M, Quittet P, Papadaki HA, Selleslag D, Viallard JF, Kaiafa G, Janssens A, Kozak T, Wadenvik H, Schoonen M, Belton L, Kreuzbauer G.

Eur J Haematol. 2017 Feb;98(2):112-120. doi: 10.1111/ejh.12807. Epub 2016 Sep 26.

PMID:
27557853
38.

Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases.

Melboucy-Belkhir S, Khellaf M, Augier A, Boubaya M, Levy V, Le Guenno G, Terriou L, Lioger B, Ebbo M, Morin AS, Chauveheid MP, Michel M, Belkhir F, About F, Rose C, Moulis G, Mekinian A, Stirnemann J, Papo T, Cheze S, Rosenthal E, Viallard JF, Schleinitz N, Galicier L, Adoue D, Lambotte O, Hamidou M, Godeau B, Fain O.

Am J Hematol. 2016 Dec;91(12):E499-E501. doi: 10.1002/ajh.24529. Epub 2016 Aug 22. No abstract available.

39.

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

Mahévas M, Gerfaud-Valentin M, Moulis G, Terriou L, Audia S, Guenin S, Le Guenno G, Salles G, Lambotte O, Limal N, Viallard JF, Cheze S, Tomowiak C, Royer B, Neel A, Debouverie O, Hot A, Durieu I, Perlat A, Cliquennois M, Deteix C, Michel M, Godeau B.

Blood. 2016 Sep 22;128(12):1625-30. doi: 10.1182/blood-2016-03-704734. Epub 2016 Jun 27.

PMID:
27354722
40.

Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series.

Selle F, James C, Tuffigo M, Pillois X, Viallard JF, Alessi MC, Fiore M.

Semin Thromb Hemost. 2017 Feb;43(1):48-58. doi: 10.1055/s-0036-1584568. Epub 2016 Jun 15.

41.

Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia.

Fiore M, Saut N, Alessi MC, Viallard JF.

Platelets. 2016 Dec;27(8):828-829. Epub 2016 Jun 8. No abstract available.

PMID:
27276516
42.

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B; Group for the PGRx-ITP Study.

Haematologica. 2016 Sep;101(9):1039-45. doi: 10.3324/haematol.2016.146373. Epub 2016 May 26.

43.

Spleen Histologic Appearance in Common Variable Immunodeficiency: Analysis of 17 Cases.

Furudoï A, Gros A, Stanislas S, Hamidou M, Furudoï E, Oksenhendler É, Merlio JP, Viallard JF, Parrens M.

Am J Surg Pathol. 2016 Jul;40(7):958-67. doi: 10.1097/PAS.0000000000000661.

PMID:
27158760
44.

A diagnostic approach that may help to discriminate inherited thrombocytopenia from chronic immune thrombocytopenia in adult patients.

Fiore M, Pillois X, Lorrain S, Bernard MA, Moore N, Sié P, Viallard JF, Nurden P.

Platelets. 2016 Sep;27(6):555-62. doi: 10.3109/09537104.2016.1143920. Epub 2016 Mar 30.

PMID:
27025585
45.

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].

Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16. French.

PMID:
26899776
46.

Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France.

Rivoisy C, Besse B, Girard N, Lioger B, Viallard JF, Lega JC, Rullier P, Perlat A, Lerouge D, Clement-Duchene C, Ebbo M, Bosseray A, Godeau B, Lambotte O.

J Thorac Oncol. 2016 Mar;11(3):391-9. doi: 10.1016/j.jtho.2015.11.012. Epub 2016 Jan 4.

47.

NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia.

Ebbo M, Audonnet S, Grados A, Benarous L, Mahevas M, Godeau B, Viallard JF, Piperoglou C, Cognet C, Farnarier C, Harlé JR, Schleinitz N, Vély F.

Clin Immunol. 2017 Apr;177:18-28. doi: 10.1016/j.clim.2015.11.005. Epub 2015 Nov 18.

PMID:
26598010
48.

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Newland A, Godeau B, Priego V, Viallard JF, López Fernández MF, Orejudos A, Eisen M.

Br J Haematol. 2016 Jan;172(2):262-73. doi: 10.1111/bjh.13827. Epub 2015 Nov 5.

PMID:
26537623
49.

Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.

Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly KH, Pertuiset E, Roblot P, Ruivard M, Subra JF, Viallard JF, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2016 Mar;68(3):690-701. doi: 10.1002/art.39450.

50.

Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence.

Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, Delain JC, Viallard JF.

Autoimmun Rev. 2016 Jan;15(1):71-81. doi: 10.1016/j.autrev.2015.09.002. Epub 2015 Sep 16. Review.

PMID:
26384525

Supplemental Content

Loading ...
Support Center